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Abstract
Background: Integrated care has emerged in a variety of forms in industrialised countries during the past decade. It is generally
assumed that these new arrangements result in increased effectiveness and quality of care, while being cost-effective or even cost-
saving at the same time. However, systematic evaluation, including an evaluation of the relative costs and benefits of these
arrangements, has largely been lacking.
Objectives: To stimulate fruitful dialogue and debate about the need for economic evaluation in integrated care, and to outline
possibilities for undertaking economic appraisal studies in this relatively new field.
Theory: Key concepts, including e.g. scarcity and opportunity costs, are introduced, followed by a brief overview of the most
common methods used in economic evaluation of health care programmes. Then a number of issues that seem particularly relevant
for economic evaluation of integrated care arrangements are addressed in more detail, illustrated with examples from the literature.
Conclusion and discussion: There is a need for well-designed economic evaluation studies of integrated care arrangements, in
particular in order to support decision making on the long-term financing of these programmes. Although relatively few studies have
been done to date, the field is challenging from a methodological point of view, offering analysts a wealth of opportunities. Guidance
to realise these opportunities is provided by the general principles for economic evaluation, which can be tailored to the requirements
of this particular field.
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Introduction
Integrated care is a relatively new field, which scope
and definition is intensively debated. In a contribution
to this debate, Spreeuwenberg and Kodner w1x noticed
that some authors are inclined to define integration
predominantly as a hierarchical or ‘top-down’ process
driven by generalised organisational exigencies for
perfection and optimisation, whereas other authors
promote a patient-centred or ‘bottom-up’ view in which
the characteristics and needs of specific patient
groups, and their fit with existing systems of care
and cure more or less determine the what, how and
where of integration. Representing the latter group
of authors, Spreeuwenberg and Kodner propose to
define the term ‘integrated’ as a coherent set of
methods and models on the funding, and the admin-
istrative-, organisational-, service delivery- and clinical
levels designed to create connectivity, alignment and
collaboration within and between the cure and care
sectors. While limiting the focus to patients with
complex, long term problems cutting across multiple
services, the results of such multi-pronged efforts to
promote integration for the benefit of these patients
would be called ‘integrated care’. In a similar vein, but
more comprehensive, Hardy et al. w2x state that inte-
grated care refers to a coherent and co-ordinated set
of services, which are planned, managed and deliv-
ered to individual service users across a range of
organisations and by a range of co-operating profes-
sionals and informal carers. In their view, integrated
care covers the full spectrum of health and health
care-related social care, while it is also inextricably
linked to other services that enable people to be
properly cared for in their own homes and in their own
communities. The essence of integrated care would
be to provide individuals with care services they are
in need of, when and where they need them. Inte-
grated care would appear seamless to the service
recipients and would be devoid of overlap or gaps to
service commissioners and providers. At the same
time, these authors acknowledge that, in practice,
integrated care appears in a variety of forms: ‘trans-International Journal of Integrated Care – Vol. 4, 1 March 2004 – ISSN 1568-4156 – http://www.ijic.org/
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mural care’, ‘shared care’, ‘disease management’,
‘integral care’, ‘comprehensive care’, ‘continuing care’,
‘intermediate care’ and so on, partly reflecting diffe-
rent countries of origin and differences in scope and
approach. For example, transmural care encompass-
es many different forms of care directed towards
bridging the gap between generalised and specialised
care for both acute and chronic patients, with origins
in the Dutch health care system w3x. According to
Rosendal w4x the concept of integrated care is more
comprehensive than the concept of transmural care
since transmural care generally does not include the
whole care process of patients but instead tends
to focus on one or two crucial transition-steps be-
tween different types of health care providers. Also, in
Rosendal’s view, transmural care is similar to ‘shared
care’ and ‘hospital at home care’ in the UK, and
(rather) different from ‘disease management’ and
‘managed care’, which both originate from the US.
The author states that the latter two approaches more
closely match the comprehensive definition of inte-
grated care presented earlier. Integrating these views,
it is perhaps fair to state that in the past decade a
large variety of new care arrangements has emerged
which, despite clear differences, are more and more
frequently referred to as (alternative forms of) inte-
grated care. Integrated care thus may become rather
an umbrella term, uniting a field, than an exact defi-
nition for all its variations in practice. For reasons of
clarity and understanding, in this article integrated
care is referred to as a comprehensive concept, while
distinguishing between different arrangements on a
more detailed level where appropriate.
Integrated care arrangements have emerged for a
variety of reasons. In the UK, for example, the devel-
opment of shared care relates to the policy of shifting
the balance from secondary to primary care w5x where-
as in the Netherlands, transmural care was concep-
tualised in particular as a means to integrate primary
health services and hospital services w6x. In these and
other countries, the ageing of the population and the
concomitant increase of citizens suffering from non-
communicable disease in general and chronic disease
in particular, are regarded as major drivers of the
development of integrated care w7x. Related to this,
the importance of integrated care arrangements is
expected to increase, exemplified by the establish-
ment of this journal, the (forthcoming) creation of a
Society for Integrated Care and a concomitant
increase in research activities in the field, perhaps in
particular in the EU w7x.
It is generally assumed that integrated care results in
increased effectiveness and quality of care, while
being cost-effective or even cost-saving at the same
time w1–3, 6x. Although many authors agree that
integrated care holds a great promise, they warn
against expectations that may be unrealistic, while
supporting an evaluative approach w1, 3–5x. For
example, in a PhD thesis on economic evaluation of
end-stage renal disease treatment in The Netherlands,
the author states that: ‘in the context of an efficient
use of resources for research, economic evaluation of
health care programmes should be oriented increas-
ingly to interventions at the level of the organisation
of care or the organisation of the health care system
in general, rather than to the plethora of interventions
at the micro level of care and prevention’ (translation
HV) w8x. Analysts in the field agree, indicating that in
the Dutch context the effectiveness and efficiency of
transmural care has hardly been addressed w3x. Like-
wise, in the UK the concern has been expressed that
‘we know too little about the relative cost-effectiveness
of providing care in different settings and by profes-
sionals with different types of training’ w5x. In addition,
a recent review of the development of integrated care
in 6 EU countries indicates that, despite many initia-
tives, most of these programmes may not yet have
achieved their full potential w7x. The combination of
these findings indicate a need for evaluation in general
and economic evaluation in particular as, due to the
relative immaturity of the field, many integrated care
programmes are short-lived after initial funding by
temporary subsidies and grants at either local or
national levels runs out. A positive decision on long-
term financing or reimbursement of services can be
facilitated by a timely and high-quality economic eval-
uation demonstrating ‘value for money’ of the pro-
gramme in question. Likewise, an economic evaluation
combined with a budget impact analysis could support
decision making on permanent reallocation of some
share of e.g. existing hospital andyor home care
budgets on behalf of an integrated care arrangement,
thus contributing to its long-term survival. In this con-
text this paper intends to stimulate research efforts in
this field by providing a brief overview of economic
evaluation methods and by discussing a number of
issues that seem particularly relevant for economic
evaluation of integrated care. In doing so, it has been
taken into account that there are quite many different
forms of integrated care. As a consequence, concepts
are illustrated on the basis of studies evaluating both
transmural care-, hospital at home care-, and man-
aged care programmes. The choice of issues has
been determined on the basis of general requirements
for any economic evaluation, as formulated in the
excellent textbook by Drummond and colleagues w9x,
geared towards integrated care as a result of a plenary
discussion following a presentation of a draft version
of this paper at the WHOyIJIC International Confer-
ence on New Research and Developments in Inte-International Journal of Integrated Care – Vol. 4, 1 March 2004 – ISSN 1568-4156 – http://www.ijic.org/
3 This article is published in a peer reviewed section of the International Journal of Integrated Care
grated Care, held in Barcelona, Spain, 21–22
February 2003.
Scarcity and economic evaluation
Rapid technological change, the ageing of the popu-
lation, and increased expectations of the public con-
stitute the three major pressures on health services in
most industrialised nations, challenging the financial
sustainability of health care systems and widely held
values of equal access to high quality care. In other
words, resources—people, time, facilities and knowl-
edge—are scarce. Choices must and will be made
concerning the deployment of resources, in this case
to develop and implement integrated care arrange-
ments. In fact, the real costs of committing resources
to a particular use is not the number of euros, dollars
or other currency appearing on the programme bud-
get, but rather the health outcome achievable in some
other programme which have been forgone by com-
mitting the resources in question to the first pro-
gramme. It is this ‘opportunity cost’ which can be
estimated and compared with programme benefits by
means of economic analysis w9x.
Two features characterise economic analysis, which
is also called economic appraisal. Firstly, it deals with
both the inputs and outputs, or costs and conse-
quences, of activities. Secondly, economic analysis
concerns itself with choices. The two characteristics
of economic evaluation have led to its definition as
the comparative analysis of alternative courses of
action in terms of both their costs and consequences
w9x. Economic evaluation of integrated care thus
involves a comparison of its costs and consequences
to one or a combination of its most appropriate com-
parators, e.g. care provided in the ‘usual’ setting.
There are a number of forms of economic evaluation
w9, 10x. The simplest form of analysis considers only
costs. This approach is justified where it can be
assumed, or has been shown, that the alternative
programmes or therapies being compared produce
identical outputs. The economic evaluation is then es-
sentially a search for the least cost alternative. An
example of such a study, termed a cost-minimisation
study, is the one by Shepperd et al. (1998), who
conducted an economic evaluation alongside a ran-
domised clinical trial with 3 months follow-up, compar-
ing hospital at home care with inpatient hospital care
for a wide variety of patients, e.g. recovering from hip-
or knee replacement. The results of the study were
reported in two consecutive articles, the first focusing
on health outcomes and the second on the efficiency
of the competing care programmes w11, 12x. The latter
study was reduced to a cost-minimisation analysis, as
the analysis of the clinical study demonstrated that
there were no major differences in patient’s reported
health outcomes between the two arrangements. To
date, this form of analysis may have been used most
frequently in evaluation of integrated care.
The other forms of economic evaluation differ mainly
in the method of measuring the outputs. In a cost-
effectiveness analysis, outputs are expressed in the
most convenient natural units or health effects, such
as ‘number of cases successfully treated’ or ‘years of
life gained’. Analyses like these presuppose that the
costs of care are related to a single, common effect,
which may differ in magnitude between the alternative
programmes. When instead it is deemed more appro-
priate to present an array of output measures, the
associated analysis is termed a cost-consequence
analysis.
This is often related to the fact that much modern
medicine is concerned not only with improving quan-
tity, but also quality of life. To assess quality of life,
an impressive number of instruments has been devel-
oped, usually distinguishing between disease-specific
and generic questionnaires. The latter questionnaires
allow comparisons of the quality of life between differ-
ent patients groups, and between patient groups and
the general population. For similar reasons as those
underlying the development of quality of life question-
naires, there has also been a growth of interest in
cost-utility analysis, where the life-years gained from
treatment are adjusted by a series of utility weights
reflecting the relative values individuals place on dif-
ferent states of health. In creating these adjustments,
health economists are basically attempting to ascer-
tain how much better the quality of life in one health
situation or ‘state’ is compared with another. An exam-
ple is dialysis at home with help from a spouse or a
friend versus dialysis in the hospital (see w8x). The
output measure most frequently used is known as the
quality-adjusted life year (QALY), which is particularly
useful for comparing the efficiency of alternative pro-
grammes with differences in both mortality and quality
of life. A less frequently used outcome measure is the
Healthy Years Equivalent (HYE) w9x. Finally, in a cost-
benefit analysis, the outputs of a programme are, just
as the costs, expressed in money terms, usually the
currency of the country of study, in order to make
them commensurate with the costs of the intervention.
An example of a study using an analytical technique
that is often applied in cost-benefit analysis to assess
the value of outcomes, is provided by a study by
Barner et al. (2001), assessing asthma patients’ Will-
ingness to pay (WTP) for and give time to an asthma
self-management programme w13x. In other cases, a
WTP approach is applied to both patients and informalInternational Journal of Integrated Care – Vol. 4, 1 March 2004 – ISSN 1568-4156 – http://www.ijic.org/
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Table 1. Types of economic evaluation
Type of evaluation Cost measurement Outcome measurement Outcome valuation
Cost-minimisation Any currency Assumed equivalent or demonstrated No valuation
equivalent
Cost-effectiveness Any currency Single major outcome common to No valuation
alternatives being evaluated, but Common units e.g.
achieved to different degrees number of lives saved
Cost-utility Any currency Single or multiple effects, common or Valuation, with results
unique to the alternatives and expressed in e.g. Quality-
achieved to different degrees Adjusted Life Years (QALYs)
Cost-benefit Any currency Any effects produced by the Valuation, with results
alternatives expressed in currency units
(Source: modified after w16x).
caregivers. Yet another example, but now exclusively
geared towards informal caregivers, is the study by
Chiu et al. (1999), assessing the willingness of fami-
lies caring for victims of stroke to pay for in-home
respite care w14x. In contrast with the previous analytic
techniques, where results are expressed as a ratio,
the results of cost-benefit analyses are expressed as
a net benefit (or cost) w15x. The different types of
economic evaluation are summarised in Table 1.
Of the different types of economic evaluation, cost-
benefit and cost-utility analysis enable decision-mak-
ers to assess broader choices, since they address the
issue of outcome valuation. Cost-benefit analyses can
also shed light on whether the programmes concerned
are ‘worth while’ when compared to other programmes
within and outside the health care sector. In princi-
ple, this is highly relevant in case of integrated care
arrangements, some of which incorporate a combina-
tion of health and non-health services. Cost-minimi-
sation and cost-effectiveness analysis tacitly assumes
that the treatment objective is worth meeting, and
generally address more restrictive questions w9x.I n
general, the choice of analytic methods should fit the
decision making process to be supported.
Selected issues in economic eval-
uation of integrated care arrange-
ments
A comparison of two or more alterna-
tives that need to be described
comprehensively
To be categorised as a full economic evaluation, a
study needs to examine both costs and effects of the
alternative programmes to be compared. Most likely a
comparison will involve ‘usual care’, or, more specifi-
cally, ‘care in the usual setting’ as comparator, which
may be e.g. regular hospital care, nursing home care,
or care provided in hospices w17, 18x. In some cases,
it may be difficult to choose the most relevant com-
parator(s). In the Netherlands, for example, seven
categories of transmural care have been distin-
guished, of which some are aimed at a single patient
group, e.g. diabetes patients w3x. After making the
correct choice of comparator, the alternatives need to
be described comprehensively. This allows the reader
the opportunity to assess whether the results can be
transferred to a local setting. For example, in the trial
by Richards et al. (1998), patients randomised to
hospital at home care received early discharge with
home based rehabilitative care between 08.30 and
11 pm provided by a team of two nurses, a physio-
therapist, an occupational therapist and three support
workers w19x. The services provided were those for
health care, with minimal essential domestic tasks
performed, with a case load of 12 patients at any one
time or less, with discharge (of hospital at home care)
when patients could be managed by routinely availa-
ble community services w19, 20x.
Viewpoint for the analysis and decision-
making context
Health economists recommend to state a viewpoint
for the analysis and to place the study in a decision-
making context. Possible viewpoints include those of
the provider institution, the individual clinician or
professional organisation, the patient, the purchaser
of health care (or third party payer) or society as a
whole. A broad societal viewpoint is recommended by
most analysts. This is because data can usually be
disaggregated and the analysis carried out from a
number of viewpoints. Also, the additional costs of
adopting a broader perspective at the outset of the
study is probably less than the cost of attempting to
gather additional information later w9, 21x. As noticed
earlier, this is relevant in case of integrated care. For
example, in the economic evaluation carried outInternational Journal of Integrated Care – Vol. 4, 1 March 2004 – ISSN 1568-4156 – http://www.ijic.org/
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Table 2. Types of costs in an economic evaluation, depending on the perspective of the analysis
Perspectives Types of costs Examples
1 2 3 Hospital costs Inpatient and/or outpatient medical staff time, nursing staff time,
other staff time, diagnostic tests, procedures, drugs, anaesthesia,
materials, and overhead costs, e.g. electricity, heating, and
administration costs
1 2 Primary care costs General practitioner time, practice nurse time, visits to
physiotherapists, etc., prescription drugs (excluding co-
payments), supplies (e.g. dressings), overheads
1 2 Costs of integrated care Professional home care, costs of training and employing e.g.
arrangements, not yet liaison or transfer nurses or otherwise specialised hospital or
covered by the previous home nurses, training programmes for GPs and other personnel,
categories costs of diagnostic tests andyor test facilities, including overheads,
consultation of medical specialists and GPs, costs of special
arrangements, e.g. rehabilitation wards, development and supply
of educational programmes for specific patient groups, etc.
1 Costs borne by the Travel expenses by the patient andyor accompanying family and
patient, family and friends, travel time, out-of-pocket expenses, including co-
friends payments, e.g. for medication, purchase of items for hospital stay,
adaptation of the home, other expenses associated with informal
caring, including e.g. lost housework time and lost leisure time
1 Costs in other sectors, Days at work, both paid and unpaid, with reduced productivity due
e.g. costs of production to illness, days off work due to illness, (partial) disability, and
losses production losses related to premature death of the patient. Days
off paid and unpaid work of informal caregivers.
(1ssocietal perspective, 2shealth care perspective, 3shospital perspective).
(Source: modified after w10, 18x).
alongside a clinical trial by Richards et al. w19, 20x,i t
was attempted to include the viewpoints of both the
NHS, social services, and patients. The viewpoints
fitted with the aim of the study, evaluating the effect-
iveness and acceptability of an early discharge, hos-
pital at home scheme and acute hospital care for
medically stable elderly patients. It can be added that
the relatively important role of informal care in a
number of integrated care programmes supports the
choice of a broad societal perspective. An example is
provided by an arrangement in Denmark, where an
informal caregiver is allowed to stay home from paid
work to care for a terminally ill family member.
Assessment of effectiveness
The quality of an economic evaluation is to a large
extent determined by the quality of the evidence of
effectiveness of health care programmes. The availa-
bility (and if available, the quality) of evidence of
effectiveness is almost always a problem, and this
goes as well for the field of integrated care. Of the
different designs that can be used to generate evi-
dence on effectiveness, the randomised controlled
clinical trial is generally acknowledged as providing
the highest quality evidence. However, in an assess-
ment of research done in the UK it was stated that
few randomised controlled clinical trials of hospital at
home services have been done, and that most of
these have been small, with little attempt at economic
evaluation w22x. So when considering economic eval-
uation of integrated care programmes, perhaps three
issues related to the quality of evidence on effective-
ness need to be addressed:
1. For which programmes does reliable evidence of
effectiveness exist, and does this provide an ade-
quate basis for economic evaluation?
2. For which programmes are clinical trials being
planned and is there any scope for undertaking
economic analysis alongside these trials? (see e.g.
w23x, for more information on this issue)
3. For which major applications of integrated care is
there yet no reliable evidence of effectiveness and
what efforts should be made to assemble such
evidence?
With regard to these latter points, a meta-analysis
of interventions used in disease management pro-
grammes for patients with chronic illnesses is illustra-
tive w24x. In this particular study, six interventions were
distinguished: provider education (materials or instruc-
tion given to healthcare providers regarding appropri-
ate care for patients with the condition targeted by the
programme); provider feedback (information to health
care providers regarding the specific care or results
of care received or experienced by their patients);International Journal of Integrated Care – Vol. 4, 1 March 2004 – ISSN 1568-4156 – http://www.ijic.org/
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provider reminders (prompts given to providers to
perform specific patient care tasks); patient education
(materials and instructions issued to patients provid-
ing information on their condition and how it could be
managed); patient reminders (prompts given to pa-
tients to perform specific tasks related to care for their
condition); and patient financial incentives (payments
(direct monetary payments, discounts or services)
made to patients for achieving specific treatment relat-
ed goals). It was concluded that, although these
different interventions were associated with improve-
ments in provider adherence to guidelines and patient
disease control, the studies did not directly compare
different interventions and that, therefore, less is
known about which interventions produce the greatest
relative improvements in care. It was therefore rec-
ommended to organise additional studies to deter-
mine the effects and costs of individual intervention
strategies.
Ideally, an economic evaluation may be contemplated
in direct association with the results from an overview
of clinical studies. Typically, the economic analyst
would take the respective point estimate of effect from
the overview as a base case value and use the
confidence interval as the relevant range for sensitivity
analysis w21x. With increased research efforts, this
option may become realistic in the field of integrated
care in a few years time. Finally, an ad hoc synthesis
of effectiveness data from several sources, including
expert opinion, is regarded as justifiable when no well-
controlled clinical studies have been performed w21x.
Given the relative lack of evidence on the effective-
ness of integrated care, this is a relevant approach
when contemplating new economic appraisal studies.
Assessment of costs
To start with, the range of costs to be included in a
given evaluation will be closely related to the viewpoint
or the perspective of the analysis. Three categories
of costs can be identified, health care costs, costs
borne by the patients and their relatives, and costs in
other sectors, such as costs in the social sector or
costs associated with production losses, e.g. due to
absence of work. Table 2 provides examples of each
of these types of costs and their relation to the choice
of perspective for an analysis. In general, the identifi-
cation of relevant categories of resource use is fol-
lowed by measurement of the quantities of the
resources used and their valuation in money terms.
The health care resources consumed consist of the
costs of organising and operating the programme. The
identification of these costs often amounts to the listing
of the ingredients of the programme—both variable
costs such as the time of health professionals or
supplies, and fixed or overhead costs such as light
heat, rent or capital costs w9x. This means that when,
for example, evaluating a rehabilitation programme of
stroke patients in a hospital at home setting with
attendance at a day centre compared to the standard
alternative intervention (rehabilitation in a long stay
hospital) it is necessary to take into account both the
time of the various professionals involved, the time of
secretaries and administrators who help run the serv-
ice, the cost of food and drugs of stroke patients and
a fraction of the capital cost of building the day centre
and maintaining a transport service to it w25x. But also
when comparing transmural care with outpatient care,
overhead costs may be important to consider. For
example, in a study in The Netherlands comparing
the effects and costs of initiation of insulin therapy in
type 2 diabetes patients in a transmural care setting
and a secondary outpatient care setting, representing
usual care, it was calculated that overhead costs
contribute 24 and 7%, respectively, of total health care
costs in the first year after treatment initiation w26x.
There may be considerable differences between coun-
tries in this respect. Coast et al. (2000) report that in
the UK typically between 25 and 35% of total hospital
costs relate to overhead costs, 30% to 40% relate to
specialty level costs (for example medical staffing),
whilst the direct costs of ward staffing make up only
30–40% of an inpatient bed day w18x.
Common benefits of quite a few integrated care
arrangements that may result in savings compared to
usual care are a reduction of hospital stay or, perhaps
less commonly, avoiding hospitalisation altogether
w17x. How should this be valued? Clearly, it is not
satisfactory to take the daily cost of hospitalisation as
an estimate of these savings, since the vacated beds
will either be filled by other patients, or, if they remain
empty, still incur a cost w15x. Therefore, the impact of
integrated care programmes on the use of other
resources needs to be assessed in the local setting,
in the knowledge of managerial actions taken to re-
deploy resources. Other authors have pointed to the
fact that the possibility to redeploy resources may
be dependent on the size of the integrated care
programme. A hypothetical example to illustrate this
issue, in economists’ terms relating to economies of
scale of integrated care programmes, is provided by
Coast et al. (2000) w18x. A small programme, taking
5 patients per week from the hospital, may lead to a
release of resources for consumables; at 10 patients
per week some staff time may be released, and at 20
patients per week it would be possible to close a
small ward. It is clear that, according to these authors,
a threshold volume must be reached in order to
achieve substitution. Following this type of reasoning,International Journal of Integrated Care – Vol. 4, 1 March 2004 – ISSN 1568-4156 – http://www.ijic.org/
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the problem may be particularly acute where shared
or integrated care programmes are drawing patients
from more than one hospital. In this case such a
programme needs to be of sufficient size to achieve
these threshold volumes in each hospital. In other
words, in considering to perform an economic evalu-
ation the sheer size of the integrated care programme
and its structuring may determine its potential cost-
effectiveness, at least from a health care sector
perspective.
Costs borne by the patient and his or her relatives
usually include the costs of travel time, waiting time,
and the costs of e.g. over-the-counter medication. A
more complex issue is the valuation of resources
invested by informal caregivers, who usually are more
heavily burdened by integrated care programmes than
by conventional care schemes, either by having to
learn medical techniques or care for relatively sick
relatives at home w1x. A comprehensive introduction
and a practical approach to these issues is provided
by Van Busschbach and colleagues (1998), in a study
providing an outline for a cost-effectiveness analysis
of a drug for patients with Alzheimer’s disease w27x.
The authors suggest a shadow-price method to value
resource use of informal caregivers. Firstly, all care-
giving and supporting activities that an informal care-
giver might perform should be listed with those
activities that could be performed by formal caregivers
or other professional aids. The next step is to assign
an hourly wage rate to each specific activity. Some
activities (e.g. making a bed) will be valued at a lower
hourly rate than others (specific caregiving). In this
way, a uniform valuation of the activities by all care-
givers can be established.
There is debate about whether the costs of production
losses should be included in an economic evaluation.
Some analysts argue that it introduces inequalities
between those interventions that are aimed at individ-
uals who could potentially return to productive activity
and those that are not. Other analysts state that
inclusion of these costs follows straightforward from a
societal perspective of analysis. It is therefore, rec-
ommended, when included in a study, to report these
costs separately, allowing readers the opportunity to
interpret study findings with and without taking these
costs into account w21x. In case of integrated care
arrangements, inclusion of the costs of production
losses may not be of paramount importance when
evaluating arrangements for elderly patients, most of
whom may be retired. The same consideration holds
for arrangements aimed at children, who are not yet
part of the workforce. However, in evaluating arrange-
ments primarily aimed at working-age populations,
inclusion of costs of production losses may be highly
appropriate. Two different methods are available for
this purpose, with the human-capital method using
lost earnings until retirement as a proxy for lost
production, while the friction-cost method uses lost
earnings until the time of replacement of the patient
as a measure of lost production. Which of these
methods is most appropriate is still debated in the
health economics literature.
Adjustment for differential timing of
costs and consequences in the analysis
A bird in the hand is worth two in the bush. In health
as well as in money terms, we value a benefit today
more highly than we value a promise of the same
benefit in 5 years’ time w25x. Therefore, when the costs
or benefits of an intervention will occur at least after
1 year in the future, a technique called discounting is
used to tackle time preferences w21x. In evaluation of
integrated care, discounting of costs and health effects
is an important issue, as many of these arrangements
are aimed at patients with a chronic condition. More
formally, when discounting, the value of the costs and
consequences that occur in 10 years are reduced, as
they are multiplied with the factor 1y(1qr) , where r t
is the chosen discount rate. For example, a cost of
5000 7 that has to be paid after 3 years, will with a
discount rate of 5% have a present value of 4319 7,
Likewise, the present value of a health benefit of 250
QALY’s gained after 5 years, will with a 5% discount
rate be the same as the gain of 196 QALY’s today
w18x. The exact choice of discount rate is the govern-
ment recommended rate, usually between 3 and 6%,
and a common rate found in the literature is 5% per
year. It is also helpful to provide the undiscounted
data to allow the reader to recalculate the results
using any discount rate w21x.
Dealing with uncertainty in the
estimates of costs and consequences
Without proper consideration of uncertainty the reader
may be unable to judge whether conclusions are
meaningful and robust. In economic evaluations of
integrated care arrangements it seems essential to
include e.g. uncertainties surrounding the reduction in
the length of stay in the sensitivity analysis, as it
usually is (one of) the most important source(s) of
potential cost-savings.
For example, Shepperd (1998), showed that for pa-
tients recovering from a hysterectomy, total health
service costs were significantly higher for those allo-
cated to hospital at home care compared to hospital
care w12x. When subjected to a sensitivity analysis, itInternational Journal of Integrated Care – Vol. 4, 1 March 2004 – ISSN 1568-4156 – http://www.ijic.org/
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was demonstrated that a one day reduction in the
length of hospital stay of hospital at home care elimi-
nated the cost difference between these settings,
while a two day reduction altered the results so that
hospital at home care became significantly less costly
than hospital care. In other words, the results of this
study were highly sensitive to uncertainties with regard
to the length of stay, at least for the particular group
of patients, which was reflected in the discussion of
the findings. In another study, with a 3 month follow
up, it was concluded that, from the combined viewpoint
of the NHS and social services, the cost of hospital at
home care were less than that of hospital care for
medically stable elderly patients w20x. The conclusion
was only sensitive to uncertainty when assuming
hospital costs to be less than 50% of those used in
the initial analysis, indicating that the findings were
relatively robust. These examples demonstrate the
crucial role of performing a sensitivity analysis as part
of an economic evaluation.
Generalisability of the findings
Of all other issues that may need to be addressed
when undertaking and reporting an economic evalua-
tion, the generalisability of the findings may be one of
the most important. As noted earlier, it is essential,
when considering the generalisability of a study, that
the programmes and interventions have been compre-
hensively described. However, authors of studies eval-
uating new care structures have been criticised for
not doing so, e.g. Sowden et al. (1995) w28x, stated
that ‘shared care is used as a ‘black box’ which has
a different content in different studies («). The
authors continue: ‘Until we have clearer definitions of
the key features of a programme of shared care,
evaluations will be of limited use, not least because
those aspects of shared care that might be important
in influencing process and outcome will remain
unclear’. From a health economics perspective, it can
be added that one of the essential features of a
programme that need to be reported is related to its
size (see earlier), as this co-determines its potential
cost-effectiveness.
Conclusion and discussion
Economic evaluation of integrated care arrangements
is a challenging and interesting area of research,
offering many opportunities. Guidance to realise these
opportunities is provided by the general principles for
economic evaluation, which can be tailored to suit the
evaluation of different forms of integrated care. How-
ever, few evaluations have been reported to date.
Reasons may be the complexity of the intervention,
the fact that evaluation of integrated care arrange-
ments may require detailed data collection across the
health care system, the necessity (at least in some
arrangements) to take into account other sectors than
the health sector as well, the inclusion of a substantial
percentage of patients with co-morbidity, and the
situation that integrated care programmes may cover
multiple patient groups. Therefore, on the one hand
economic analysis in this field may be more compli-
cated than in case of single technologies or interven-
tions, but on the other hand the results of these
studies may support decision making processes that
affect the organisation of the health care system and
the care processes in multiple patient groups at the
same time.
A major issue in evaluating integrated care is the
choice of design of the study, as this co-determines
the quality of the evidence of on effectiveness, which
impacts on any subsequent analysis of the cost-
effectiveness of the arrangement. Although this arti-
cle has provided a number of examples of studies
designed as randomised controlled trials, several
authors have pointed at inherent difficulties associated
with this design in evaluating specific integrated care
arrangements, suggesting comparative cohort studies
and audit-type approaches instead, comparing ‘usual-
care’ settings with integrated care settings w4, 29x.
Also in this situation, integration of an economic
evaluation may be useful. An example of a compara-
tive cohort-study is provided by Polder et al. (2002)
evaluating costs and effects of a conventional dis-
charge policy after hip fracture versus an early dis-
charge policy in which patients were rehabilitated in a
specialised nursing home w30x. In explaining the
design of the study, the authors state that randomi-
sation of patients was not considered feasible since
the change from conventional discharge to early dis-
charge arrangements required such organisational
adjustments that both service models could not be
offered simultaneously. Despite the methodological
disadvantages of such studies, the findings may still
be useful to support reimbursement decision making
in a situation where, according to Van der Linden et
al. (2001) w29x, most of the current transmural projects
are experiencing difficulties in obtaining permanent
funding after the conclusion of the experimental
phase. A general issue of concern, however, is the
demand-generation effect of integrated care pro-
grammes. Since a considerable proportion of such
programmes enable the patient to be treated at home
while reducing the length of hospital stay, many cat-
egories of patients will prefer this option, and it can
therefore be expected that the limits will be pushed of
indications that are deemed eligible for care in such
settings, which may lead to inefficiencies. It is there-International Journal of Integrated Care – Vol. 4, 1 March 2004 – ISSN 1568-4156 – http://www.ijic.org/
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fore recommended to explore the cost-effectiveness
of broadening the indications of selected integrated
care programmes as part of the sensitivity analysis of
an appraisal.
This article has introduced and discussed some of the
issues that need to be addressed when contemplating
an economic evaluation of integrated care arrange-
ments. From a societal perspective, assessment of
potential savings due to reduced length of hospital
stay in integrated care arrangements and issues of
cost shifting, e.g. from the hospital to other health
care institutions, and from health services to both
social services and the patient and their relatives,
deserve special attention. For readers who wish to be
informed in more detail, the textbook by Drummond
and colleagues is recommended w9x. Finally, to guar-
antee the highest possible level of economic evalua-
tion in this field, a skilled health economist should be
consulted in the early phase of the design of the
study. Ideally, the health economist would be part of
the research team from start to finish of the project.
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